DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Clinicaltrials.Gov.
CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients with COVID-19 Infection, Nested in the CORIMUNO-19 Cohort (CORIMUNO19-ECU).
2020 . Accessed November 22, 2020 at:
https://clinicaltrials.gov/ct2/show/NCT04346797
Access:
We do not assume any responsibility for the contents of the web pages of other providers.